Lesion morphology and coronary angioplasty: current experience and analysis

San Francisco Heart Institute, Seton Medical Center, Daly City, California.

From July 1, 1990 to February 28, 1991, 533 consecutive patients with 764 target vessels and 1,000 lesions underwent coronary angioplasty. Procedural success was achieved in 92.3%, untoward (major cardiac) events occurred in 3% (0.8% myocardial infarction, 1.3% emergency coronary bypass grafting and 0.9% both; there were no deaths). An unsuccessful uncomplicated outcome occurred in 4.7%. Lesion analysis using a modified American College of Cardiology/American Heart Association classification system showed that 8% were type A, 47.5% were type B and 44.5% were type C (36% of type B and 11% of type C were occlusions). Angioplasty success was achieved in 99% of type A, 92% of type B and 90% of type C lesions (A vs. B, p less than 0.05; B vs. C, p = NS; A vs. C, p less than 0.01). Untoward events occurred in 1.2% of type A, 1.9% of type B and 2% of type C lesions (p = NS). An unsuccessful uncomplicated outcome occurred in 0% of type A, 6% of type B and 7% of type C lesions (A vs. B, p less than 0.05; B vs. C, p = NS; A vs. C, p less than 0.05). Among the unsuccessful uncomplicated outcome group, occlusion occurred in 49%: 38% of type B and 59% of type C lesions. With B1 and B2 subtypes, success was obtained in 95% and 89.5% and untoward events occurred in 1.5% and 2.3% and an unsuccessful uncomplicated outcome in 3.7% and 8%, respectively. C1 and C2 subtyping showed success in 91% and 86%, untoward events in 1.3% and 6% and an unsuccessful uncomplicated outcome in 7.5% and 8.5%, respectively. Among the 764 vessels, success was obtained in 89.5% and untoward events occurred in 2.5% and an unsuccessful uncomplicated outcome in 8%. Assessment of lesion-vessel combinations showed a less favorable outcome with type C lesions and combinations of A-B, B-C and multiple (more than three lesions) type B and C vessels. Statistical analysis of morphologic factors associated with angioplasty success included absence of (old) occlusion (p less than 0.0001) and unprotected bifurcation lesion (p less than 0.001), decreasing lesion length (p less than 0.003) and no thrombus (p less than 0.03). The only significant factor associated with untoward events was the presence of thrombus (p less than 0.003). Predictors of an unsuccessful uncomplicated outcome included old occlusion (p less than 0.0001) and increasing lesion length (greater than 20 mm) (p less than 0.001), unprotected bifurcation lesion (p less than 0.05) and thrombus (p less than 0.03).

This article has been cited by other articles:

				A. Latib and A. Colombo Bifurcation Disease: What Do We Know, What Should We Do? J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 218 - 226. [Abstract] [Full Text] [PDF]

				S. B. King III, T. Aversano, W. L. Ballard, R. H. Beekman III, M. J. Cowley, S. G. Ellis, D. P. Faxon, E. L. Hannan, J. W. Hirshfeld Jr, A. K. Jacobs, et al. ACCF/AHA/SCAI 2007 Update of the Clinical Competence Statement on Cardiac Interventional Procedures: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures) J. Am. Coll. Cardiol., July 3, 2007; 50(1): 82 - 108. [Full Text] [PDF]

				J. J. Popma, P. Berger, E. M. Ohman, R. A. Harrington, C. Grines, and J. I. Weitz Antithrombotic Therapy During Percutaneous Coronary Intervention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 576S - 599S. [Abstract] [Full Text] [PDF]

				C. M. Gibson and A. Schomig Coronary and Myocardial Angiography: Angiographic Assessment of Both Epicardial and Myocardial Perfusion Circulation, June 29, 2004; 109(25): 3096 - 3105. [Full Text] [PDF]

				M. J. Ross, H. C. Herrmann, D. J. Moliterno, J. C. Blankenship, L. Demopoulos, P. M. DiBattiste, S. G. Ellis, Z. Ghazzal, J. L. Martin, J. White, et al. Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial J. Am. Coll. Cardiol., September 17, 2003; 42(6): 981 - 988. [Abstract] [Full Text] [PDF]

				S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]

				W. Maier, O. Mini, J. Antoni, M. B. Wischnewsky, and B. Meier ABC Stenosis Morphology Classification and Outcome of Coronary Angioplasty : Reassessment With Computing Techniques Circulation, March 6, 2001; 103(9): 1225 - 1231. [Abstract] [Full Text] [PDF]

				K T Koch, J J Piek, M H Prins, R J de Winter, K Mulder, K I Lie, and J G P Tijssen Triage of patients for short term observation after elective coronary angioplasty Heart, May 1, 2000; 83(5): 557 - 563. [Abstract] [Full Text]

				E. A. Iliadis, S. M. Zaacks, J. E. Calvin, J. Allen, J. E. Parrillo, and L. W. Klein The Relative Influence of Lesion Length and Other Stenosis Morphologies on Procedural Success of Coronary Intervention Angiology, January 1, 2000; 51(1): 39 - 52. [Abstract] [PDF]

				S. G. Ellis, V. Guetta, D. Miller, P. L. Whitlow, and E. J. Topol Relation Between Lesion Characteristics and Risk With Percutaneous Intervention in the Stent and Glycoprotein IIb/IIIa Era : An Analysis of Results From 10 907 Lesions and Proposal for New Classification Scheme Circulation, November 9, 1999; 100(19): 1971 - 1976. [Abstract] [Full Text] [PDF]

				A. Kastrati, A. Schomig, S. Elezi, J. Dirschinger, J. Mehilli, H. Schuhlen, R. Blasini, and F.-J. Neumann Prognostic Value of the Modified American College of Cardiology/American Heart Association Stenosis Morphology Classification for Long-Term Angiographic and Clinical Outcome After Coronary Stent Placement Circulation, September 21, 1999; 100(12): 1285 - 1290. [Abstract] [Full Text] [PDF]

				H. L. Dauerman, P. J. Higgins, A. M. Sparano, C. M. Gibson, G. R. Garber, J. P. Carrozza Jr., R. E. Kuntz, R. J. Laham, S. J. Shubrooks Jr., D. S. Baim, et al. Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1845 - 1852. [Abstract] [Full Text] [PDF]

				S. G. Ellis, A. M. Lincoff, D. Miller, J. E. Tcheng, N. S. Kleiman, D. Kereiakes, R. Califf, E. J. Topol, and for the EPIC and EPILOG Investigators Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1619 - 1623. [Abstract] [Full Text] [PDF]

				A. Kastrati, F.-J. Neumann, and A. Schomig Operator volume and outcome of patients undergoing coronary stent placement J. Am. Coll. Cardiol., October 1, 1998; 32(4): 970 - 976. [Abstract] [Full Text] [PDF]

				I. Moussa, B. Reimers, J. Moses, C. Di Mario, L. Di Francesco, M. Ferraro, and A. Colombo Long-term Angiographic and Clinical Outcome of Patients Undergoing Multivessel Coronary Stenting Circulation, December 2, 1997; 96(11): 3873 - 3879. [Abstract] [Full Text]

				A. D. Kugelmass and G. E. Raskob Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty or Coronary Stent Placement Clinical and Applied Thrombosis/Hemostasis, October 1, 1997; 3(1_suppl): S24 - S31. [PDF]

				M. Panteghini, R. Bonora, F. Pagani, F. Buffoli, and C. Cuccia Rapid, Highly Sensitive Immunoassay for Determination of Cardiac Troponin I in Patients with Myocardial Cell Damage Clin. Chem., August 1, 1997; 43(8): 1464 - 1465. [Full Text]

				N. Reifart, M. Vandormael, M. Krajcar, S. Gohring, W. Preusler, F. Schwarz, H. Storger, M. Hofmann, J. Klopper, S. Muller, et al. Randomized Comparison of Angioplasty of Complex Coronary Lesions at a Single Center : Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study Circulation, July 1, 1997; 96(1): 91 - 98. [Abstract] [Full Text]

				I. Moussa, C. Di Mario, J. Moses, B. Reimers, L. Di Francesco, G. Martini, J. Tobis, and A. Colombo Coronary Stenting After Rotational Atherectomy in Calcified and Complex Lesions : Angiographic and Clinical Follow-Up Results Circulation, July 1, 1997; 96(1): 128 - 136. [Abstract] [Full Text]

				S. G. Ellis, W. Weintraub, D. Holmes, R. Shaw, P. C. Block, and S. B. King III Relation of Operator Volume and Experience to Procedural Outcome of Percutaneous Coronary Revascularization at Hospitals With High Interventional Volumes Circulation, June 3, 1997; 95(11): 2479 - 2484. [Abstract] [Full Text]

				C. Palmieri, M. P. R. Sicari, E. Picano, A. Biagini, and M. Marzilli Quantitative Assessment of Coronary Atherosclerotic Plaque Profile by Morphometric Analysis of Angiographic Images Angiology, November 1, 1996; 47(11): 1053 - 1059. [Abstract] [PDF]

				K. E. Kip, D. P. Faxon, K. M. Detre, W. Yeh, S. F. Kelsey, and J. W. Currier Coronary Angioplasty in Diabetic Patients: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry Circulation, October 15, 1996; 94(8): 1818 - 1825. [Abstract] [Full Text]

				S. Waxman, M. A. Sassower, M. A. Mittleman, S. Zarich, A. Miyamoto, K. S. Manzo, J. E. Muller, G. S. Abela, and R. W. Nesto Angioscopic Predictors of Early Adverse Outcome After Coronary Angioplasty in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction Circulation, June 15, 1996; 93(12): 2106 - 2113. [Abstract] [Full Text]

				J. A. Bittl, J. Strony, J. A. Brinker, W. H. Ahmed, C. R. Meckel, B. R. Chaitman, J. Maraganore, E. Deutsch, B. Adelman, and The Hirulog Angioplasty Study Investigators Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina N. Engl. J. Med., September 21, 1995; 333(12): 764 - 769. [Abstract] [Full Text] [PDF]

				S. G. Ellis, D. P. Miller, K. J. Brown, N. Omoigui, G. L. Howell, M. Kutner, and E. J. Topol In-Hospital Cost of Percutaneous Coronary Revascularization : Critical Determinants and Implications Circulation, August 15, 1995; 92(4): 741 - 747. [Abstract] [Full Text]

				M. W. Wolfe, G. S. Roubin, M. Schweiger, J. M. Isner, J. J. Ferguson, A. D. Cannon, M. Cleman, H. Cabin, F. Leya, R. Bonan, et al. Length of Hospital Stay and Complications After Percutaneous Transluminal Coronary Angioplasty : Clinical and Procedural Predictors Circulation, August 1, 1995; 92(3): 311 - 319. [Abstract] [Full Text]

				T. Kwan, M. S. Huber, H. Jani, and A. Feit Multiple Balloon Rupture During Coronary Angioplasty: A Case Report Angiology, October 1, 1994; 45(10): 891 - 896. [Abstract] [PDF]

				C. Landau, R. A. Lange, and L. D. Hillis Percutaneous Transluminal Coronary Angioplasty N. Engl. J. Med., April 7, 1994; 330(14): 981 - 993. [Full Text]